Nanoformulation of Leonotis leonurus to improve its bioavailability as a potential antidiabetic drug
Nanoformulation of Leonotis leonurus to improve its bioavailability as a potential antidiabetic drug
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Nanostructured lipid carriers (NLCs) of
Leonotis leonurus
were successfully produced using high-pressure homogenisation (HPH) on a LAB 40 homogeniser. The particle size was determined for the formulation as well as short-term stability study. The formulation was exposed to Chang liver cells for a glucose uptake study and to INS-1 cells for a...
Alternative Titles
Full title
Nanoformulation of Leonotis leonurus to improve its bioavailability as a potential antidiabetic drug
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5610593
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5610593
Other Identifiers
ISSN
2190-572X
E-ISSN
2190-5738
DOI
10.1007/s13205-017-0986-0
